ECSS
GH icon

Eurizon Capital SGR SpA’s Guardant Health GH Stock Holding History

Eurizon Capital SGR SpA’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$321K Sell
2,089
-541
-21% -$58.8K ﹤0.01% 685
2026
Q1 		$228K Buy
2,630
+397
+18% +$39.9K ﹤0.01% 730
2025
Q4 		$224K Buy
+2,233
New +$200K ﹤0.01% 643

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Eurizon Capital SGR SpA's GH Position: Q2 2026 in Review

Eurizon Capital SGR SpA reduced its Guardant Health (GH) stake by 21% in Q2 2026, selling an estimated $58.8K and leaving 2,089 shares worth $321K. The position accounts for ﹤0.01% of the portfolio, ranked #685.

Eurizon Capital SGR SpA first reported a position in GH in Q4 2025 and has held it in 3 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Eurizon Capital SGR SpA held 2,089 shares of Guardant Health worth $321K as of Q2 2026.
  • Eurizon Capital SGR SpA sold 541 Guardant Health shares in Q2 2026, an estimated $58.8K.
  • Guardant Health made up ﹤0.01% of Eurizon Capital SGR SpA's portfolio in Q2 2026, its #685 holding.
  • Eurizon Capital SGR SpA first reported a position in Guardant Health in Q4 2025 and has held it in 3 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Eurizon Capital SGR SpA's 13F filing for Q2 2026, filed 29 Jul 2026.